Case report of the reliability 1,3-β-D-glucan monitoring during treatment of peritoneal candidiasis in a child receiving continuous peritoneal dialysis

Clinical and Vaccine Immunology

Volumn 19, Issue 4, 2012, Pages 626-627

  Ginocchio, Francesca ^a   Verrina, Enrico ^a   Furfaro, Elisa ^b   Cannavò, Rossella ^a   Bandettini, Roberto ^a   Castagnola, Elio ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; CASPOFUNGIN; FLUCONAZOLE;

ARTICLE; BACTERIUM CULTURE; BLOOD CULTURE; BLOOD SAMPLING; CANDIDA PARAPSILOSIS; CANDIDIASIS; CASE REPORT; CHILD; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DISEASE ASSOCIATION; FUNGUS IDENTIFICATION; HUMAN; LIMIT OF DETECTION; MALE; OUTCOME ASSESSMENT; PATIENT MONITORING; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEAL FLUID; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SYSTEMIC THERAPY;

ASCITIC FLUID; BETA-GLUCANS; CANDIDIASIS; CHILD, PRESCHOOL; DRUG MONITORING; HUMANS; MALE; PERITONEAL DIALYSIS; PERITONITIS;

EID: 84859317022     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00008-12     Document Type: Article

References (11)

1. Del Bono V, et al. 2011. Clinical performance of (1,3)-{β}-D-glucan assay in early diagnosis of nosocomial Candida blood stream infections. Clin. Vaccine Immunol. 18:2113-2117.
2. Gandhi BV, et al. 2005. Systemic fungal infections in renal diseases. J. Postgrad. Med. 51:S30 -S36.
3. Kale-Pradhan PB, Morgan G, Wilhelm SM, Johnson LB. 2010. Comparative efficacy of echinocandins and nonechinocandins for the treatment of Candida parapsilosis infections: a meta-analysis. Pharmacotherapy 30:1207-1213.
4. Kanda H, et al. 2001. Influence of various hemodialysis membranes on the plasma (1/3)-β-D-glucan level. Kidney Int. 60:319-323. (Pubitemid 32587570)
5. Kato A, et al. 2001. Elevation of blood (1/3)-β-D-glucan concentrations in hemodialysis patients. Nephron 89:15-19. (Pubitemid 32799827)
6. Lamoth F, et al. 2012. β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin. Infect. Dis. 54:633- 643.
7. Li PK, et al. 2010. Peritoneal dialysis-related infections recommendations: 2010 update. Perit. Dial. Int. 30:393-423.
8. Mohr JF, et al. 2011. Prospective survey of (1-3)-β-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J. Clin. Microbiol. 49:58-61.
9. Mularoni A, et al. 2010. High levels of β-D-glucan in immunocompromised children with proven invasive fungal disease. Clin. Vaccine Immunol. 17:882- 883.
10. Racil Z, et al. 2010. Difficulties in using 1,3-β-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies - high frequency of false-positive results and their analysis. J. Med. Microbiol. 59:1016-1022.
11. Smith WJ, et al. 2007. Quantification of 1,3-β-D-glucan levels in children: preliminary data for diagnostic use of the β-glucan assay in a pediatric setting. Clin. Vaccine Immunol. 14:924-925.